Cinchonine

N/A

Report date: 2022/12/08 17:49:14
NME

Base Information

Drug NameCinchonine
Drug Alias NameQuinimaxCHN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitorsCell membrane permeability inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDebiopharm Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm Group
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG